Abstract
The multicenter prospective randomized control trial of single-level arthroplasty compared to anterior-posterior spinal fusion in patients with functionally-disabling discogenic back pain provided the clinical dataset for the PMA study leading to FDA-approval for ProDisc-L (TDR) in August 2006. The results of the two-year data has been previously published.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call